LYPLAL1 Rare Loss-of-Function Variants in Humans and Deletion in Human Hepatoma Cells Protect Against MASLD.

Genetic variants near LYPLAL1 are associated with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) in humans, but their impact on LYPLAL1 function is unknown. We identified LYPLAL1 loss-of-function variants from UK BioBank (UKBB) whole-exome sequencing data that had AlphaMissense or GPN-MSA scores in the top 20% of LYPLAL1 variants for being disruptive. We aggregated these variants and carried out burden analysis for effects on MRI Proton Density-Fat Fraction (MRI-PDFF) and ICD-based MASLD in UKBB. Rare loss-of-function LYPLAL1 variants were associated with reduced MRI-PDFF and ICD diagnosed MASLD across sexes. We used CRISPR to knockout and overexpress LYPLAL1 in human hepatoma cells (HuH-7), measuring lipid content, lipid uptake/export, and changes in de novo lipogenesis and mitochondrial β-oxidation. LYPLAL1 subcellular localization was determined by overexpressing LYPLAL1-HA tagged protein. We purified GST tagged human LYPLAL1 protein and conducted in vitro tests for esterase and depalmitoylase activity. Knocking out LYPLAL1 reduced triglycerides biochemically as well as lipid intensity after oleic (18:1, n-9) acid treatment. LYPLAL1 KO cells had increased expression of PPARα and MLXIPL, increased mitochondrial β-oxidation, and reduced capacity to both import fatty acids (FAs) and export lipoproteins. Overexpression of LYPLAL1 increased lipid droplet accumulation and decreased PPARα and MLXIPL. LYPLAL1-HA is partly localized to mitochondria when treated with oleic acid. Biochemical analyses showed that LYPLAL1 has strong esterase activity but lacks depalmitoylase activity. Reduction of LYPLAL1 esterase function likely increases β-oxidation of FAs in mitochondria through PPARα and MLXIPL and decreases FA import to protect against lipid accumulation in human liver cancer cells.

• Publication year

  2026

• Venue

  Journal of Lipid Research

• Publication date

  2026-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jlr.2026.101013PMID 41786251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A DNA language model based on multispecies alignment predicts the effects of genome-wide variants

  2025cited by this paper
• LYPLAL1 enzyme activity is linked to hepatic glucose metabolism.

  2025cited by this paper
• Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment

  2025cited by this paper
• Correlation between magnetic resonance imaging proton density fat fraction (MRI-PDFF) and liver biopsy to assess hepatic steatosis in obesity

  2024cited by this paper
• Depalmitoylation and Cell Physiology: APT1 as a Mediator of Metabolic Signals.

  2024cited by this paper
• Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH

  2024cited by this paper
• Current status and future trends of the global burden of MASLD.

  2024cited by this paper
• A new treatment and updated clinical practice guidelines for MASLD

  2024cited by this paper
• A functional genomic framework to elucidate novel causal metabolic dysfunction–associated fatty liver disease genes

  2024cited by this paper
• Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank

  2024cited by this paper
• NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review

  2024cited by this paper
• Etomoxir: an old dog with new tricks

  2024cited by this paper
• Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma

  2024cited by this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review

  2023cited by this paper
• PNPLA3 genotype and diabetes identify patients with non-alcoholic fatty liver disease at high risk of incident cirrhosis.

  2023cited by this paper
• Mitochondrial CPT1A: Insights into structure, function, and basis for drug development

  2023cited by this paper
• Accurate proteome-wide missense variant effect prediction with AlphaMissense

  2023cited by this paper
• Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy.

  2023cited by this paper
• The role of ChREBP in carbohydrate sensing and NAFLD development

  2023cited by this paper
• Cellpose 2.0: how to train your own model

  2022cited by this paper
• PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH)

  2022cited by this paper
• A versatile, high-efficiency platform for CRISPR-based gene activation

  2022cited by this paper
• Phenotypic Causal Inference Using Genome-Wide Association Study Data: Mendelian Randomization and Beyond.

  2022cited by this paper
• Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context

  2021cited by this paper
• Exome sequencing and analysis of 454,787 UK Biobank participants

  2021cited by this paper
• Quantification of Liver Fat Content with CT and MRI: State of the Art.

  2021cited by this paper
• Knockout of murine Lyplal1 confers sex-specific protection against diet-induced obesity

  2021cited by this paper
• ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue

  2020cited by this paper
• Endothelial Palmitoylation Cycling Coordinates Vessel Remodeling in Peripheral Artery Disease

  2020cited by this paper
• Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.

  2020cited by this paper
• Computationally efficient whole-genome regression for quantitative and binary traits

  2020cited by this paper
• Gene-by-Sex Interactions in Mitochondrial Functions and Cardio-Metabolic Traits.

  2019cited by this paper
• Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.

  2019cited by this paper
• Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis

  2019cited by this paper
• Molecular Actions of PPARα in Lipid Metabolism and Inflammation.

  2018cited by this paper
• Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy

  2018cited by this paper
• Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes

  2018cited by this paper
• Lipid transfer proteins in the assembly of apoB-containing lipoproteins

  2018cited by this paper
• Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin

  2018cited by this paper
• Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities

  2018cited by this paper
• Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis

  2018cited by this paper
• The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism

  2017cited by this paper
• LASER server: ancestry tracing with genotypes or sequence reads

  2017cited by this paper
• Lyplal1 is dispensable for normal fat deposition in mice

  2017cited by this paper
• Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults

  2016cited by this paper
• Effects of Obesity Related Genetic Variations on Visceral and Subcutaneous Fat Distribution in a Chinese Population

  2016cited by this paper
• The Warburg Effect: How Does it Benefit Cancer Cells?

  2016cited by this paper
• A fluorescent probe for cysteine depalmitoylation reveals dynamic APT signaling

  2016cited by this paper
• Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation

  2016cited by this paper
• Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine.

  2016cited by this paper
• Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease.

  2015cited by this paper
• A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity.

  2015cited by this paper
• Recent insights into the biological functions of liver fatty acid binding protein 1

  2015cited by this paper
• Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line

  2015cited by this paper
• Obesity associated Lyplal1 gene is regulated in diet induced obesity but not required for adipocyte differentiation.

  2015cited by this paper
• Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism.

  2014cited by this paper
• Metabolic profiling reveals that PNPLA3 induces widespread effects on metabolism beyond triacylglycerol remodeling in Huh-7 hepatoma cells.

  2014cited by this paper
• The autodepalmitoylating activity of APT maintains the spatial organization of palmitoylated membrane proteins.

  2014cited by this paper
• Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits.

  2013cited by this paper
• Dynamic Palmitoylation Links Cytosol-Membrane Shuttling of Acyl-protein Thioesterase-1 and Acyl-protein Thioesterase-2 with That of Proto-oncogene H-Ras Product and Growth-associated Protein-43*

  2013cited by this paper
• Distinct Acyl Protein Transferases and Thioesterases Control Surface Expression of Calcium-activated Potassium Channels

  2012cited by this paper
• A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance

  2012cited by this paper
• Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways

  2012cited by this paper
• Lipoprotein metabolism in nonalcoholic fatty liver disease

  2012cited by this paper
• Crystal structure of the predicted phospholipase LYPLAL1 reveals unexpected functional plasticity despite close relationship to acyl protein thioesterases

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012cited by this paper
• Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits

  2011cited by this paper
• Implications of Central Obesity-Related Variants in LYPLAL1, NRXN3, MSRA, and TFAP2B on Quantitative Metabolic Traits in Adult Danes

  2011cited by this paper
• Integrated Expression Profiling and Genome-Wide Analysis of ChREBP Targets Reveals the Dual Role for ChREBP in Glucose-Regulated Gene Expression

  2011cited by this paper
• Small-molecule inhibition of APT1 affects Ras localization and signaling.

  2010cited by this paper
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

  2010cited by this paper
• Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution

  2010cited by this paper
• METAL: fast and efficient meta-analysis of genomewide association scans

  2010cited by this paper
• Peroxisome Proliferator-Activated Receptor Alpha Target Genes

  2010cited by this paper
• Correction: Genome-Wide Association Scan Meta-Analysis Identifies Three Loci Influencing Adiposity and Fat Distribution

  2009cited by this paper
• Carbohydrate-response Element-binding Protein Deletion Alters Substrate Utilization Producing an Energy-deficient Liver*

  2008cited by this paper
• Adipocyte triglyceride lipase expression in human obesity.

  2007cited by this paper
• A guided tour into subcellular colocalization analysis in light microscopy

  2006cited by this paper
• ChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver*

  2006cited by this paper
• CellProfiler: image analysis software for identifying and quantifying cell phenotypes

  2006cited by this paper
• Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.

  2006cited by this paper
• Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis.

  2004cited by this paper
• Uptake of long-chain fatty acids in HepG2 cells involves caveolae DOI 10.1194/jlr.M100404-JLR200

  2002cited by this paper
• Sterol carrier protein-2 expression increases NBD-stearate uptake and cytoplasmic diffusion in L cells.

  1998cited by this paper
• Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

  1982cited by this paper
• Edinburgh Research Explorer Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women

  year unknowncited by this paper

• No citing papers are available for this paper.